Clinical trial
Efficacy of Amantadine for Gait Dysfunction and Gait Freezing in Patients With Parkinson's Disease
NCT01652534 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Amantadine for Gait Dysfunction and Gait Freezing in Patients With Parkinson's Disease
- Lead sponsor
- Northwestern University
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- June 30, 2011
- Completion date
- August 31, 2015
- Enrollment
- 3 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
parkinson's disease